{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:05:13Z","timestamp":1791255913556,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016015","name":"Universit\u00e4tsspital Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Conflicting findings exist regarding the influence of sex on the development, treatment, course, and outcome of status epilepticus (SE). Our study aimed to investigate sex-related disparities in adult SE patients, focusing on treatment, disease course, and outcome at two Swiss academic medical centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, patients treated for SE at two Swiss academic care centers from Basel and Geneva from 2015 to 2021 were included. Primary outcomes were return to premorbid neurologic function, death during hospital stay and at 30\u00a0days. Secondary outcomes included characteristics of treatment and disease course. Associations with primary and secondary outcomes were assessed using multivariable logistic regression. Analysis using propensity score matching was performed to account for the imbalances regarding age between men and women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 762 SE patients, 45.9% were women. No sex-related differences were found between men and women, except for older age and lower frequency of intracranial hemorrhages in women. Compared to men, women had a higher median age (70 vs. 66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), had focal nonconvulsive SE without coma more (34.9% vs. 25.5%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) and SE with motor symptoms less often (52.3% vs. 63.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). With longer SE duration (1\u00a0day vs. 0.5\u00a0days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011) and a similar proportion of refractory SE compared to men (36.9% vs. 36.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.898), women were anesthetized and mechanically ventilated less often (30.6% vs. 42%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Age was associated with all primary outcomes\u00a0in the unmatched multivariable analyses, but not\u00a0female sex. In contrast, propensity score-matched multivariable analyses revealed decreased odds for return to premorbid neurologic function for women independent of potential confounders. At hospital discharge, women were sent home less (29.7% vs. 43.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and to nursing homes more\u00a0often (17.1% vs. 10.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identified sex-related disparities in the clinical features, treatment modalities, and outcome of adult patients with SE with women being at a disadvantage, implying that sex-based factors must be considered when formulating strategies for managing SE and forecasting outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04592-6","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T03:02:44Z","timestamp":1691204564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sex-related differences in adult patients with status epilepticus: a seven-year two-center observation"],"prefix":"10.1186","volume":"27","author":[{"given":"Sira M.","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina S. C.","family":"Kliem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Grzonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Gebhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana E.","family":"Sarbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"De Marchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Hunziker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"R\u00fcegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Pugin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Quintard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta","family":"Seeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"issue":"10","key":"4592_CR1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus\u2013report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515\u201323.","journal-title":"Epilepsia"},{"issue":"3","key":"4592_CR2","doi-asserted-by":"crossref","first-page":"fcad145","DOI":"10.1093\/braincomms\/fcad145","volume":"5","author":"A Mevius","year":"2023","unstructured":"Mevius A, Joeres L, Gille P, Molzan M, Foskett N, Wilke T, et al. Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database. Brain Commun. 2023;5(3):fcad145.","journal-title":"Brain Commun."},{"issue":"12","key":"4592_CR3","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1007\/s00415-021-10600-y","volume":"268","author":"L Langenbruch","year":"2021","unstructured":"Langenbruch L, Strippel C, Gorlich D, Elger CE, Moddel G, Meuth SG, et al. Occurrence of status epilepticus in persons with epilepsy is determined by sex, epilepsy classification, and etiology: a single center cohort study. J Neurol. 2021;268(12):4816\u201323.","journal-title":"J Neurol"},{"issue":"5","key":"4592_CR4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00134-021-06393-3","volume":"47","author":"A Todorov","year":"2021","unstructured":"Todorov A, Kaufmann F, Arslani K, Haider A, Bengs S, Goliasch G, et al. Gender differences in the provision of intensive care: a Bayesian approach. Intensive Care Med. 2021;47(5):577\u201387.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4592_CR5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.50.3.735","volume":"50","author":"DC Hesdorffer","year":"1998","unstructured":"Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965\u20131984. Neurology. 1998;50(3):735\u201341.","journal-title":"Neurology"},{"issue":"6","key":"4592_CR6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","volume":"42","author":"S Knake","year":"2001","unstructured":"Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42(6):714\u20138.","journal-title":"Epilepsia"},{"issue":"7","key":"4592_CR7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","volume":"58","author":"YW Wu","year":"2002","unstructured":"Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58(7):1070\u20136.","journal-title":"Neurology"},{"issue":"5","key":"4592_CR8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","volume":"55","author":"A Coeytaux","year":"2000","unstructured":"Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55(5):693\u20137.","journal-title":"Neurology"},{"issue":"4","key":"4592_CR9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.58.4.537","volume":"58","author":"G Logroscino","year":"2002","unstructured":"Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA. Long-term mortality after a first episode of status epilepticus. Neurology. 2002;58(4):537\u201341.","journal-title":"Neurology"},{"issue":"6","key":"4592_CR10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1528-1157.1999.tb00774.x","volume":"40","author":"EJ Waterhouse","year":"1999","unstructured":"Waterhouse EJ, Garnett LK, Towne AR, Morton LD, Barnes T, Ko D, et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond. Virginia Epilepsia. 1999;40(6):752\u20138.","journal-title":"Virginia Epilepsia"},{"issue":"12","key":"4592_CR11","first-page":"800","volume":"11","author":"RF Chin","year":"2004","unstructured":"Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol Offic J Eur Fed Neurol Soc. 2004;11(12):800\u201310.","journal-title":"Eur J Neurol Offic J Eur Fed Neurol Soc"},{"issue":"12","key":"4592_CR12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1528-1157.1997.tb00073.x","volume":"38","author":"G Logroscino","year":"1997","unstructured":"Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38(12):1344\u20139.","journal-title":"Epilepsia"},{"issue":"9596","key":"4592_CR13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"2","key":"4592_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"12","key":"4592_CR15","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/epi.17100","volume":"62","author":"SM Baumann","year":"2021","unstructured":"Baumann SM, Semmlack S, Rybitschka A, Kliem PSC, De Marchis GM, Ruegg S, et al. Prolonged mechanical ventilation in patients with terminated status epilepticus and outcome: an observational cohort study. Epilepsia. 2021;62(12):3042\u201357.","journal-title":"Epilepsia"},{"issue":"11","key":"4592_CR16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.wnl.0000223352.71621.97","volume":"66","author":"AO Rossetti","year":"2006","unstructured":"Rossetti AO, Logroscino G, Bromfield EB. A clinical score for prognosis of status epilepticus in adults. Neurology. 2006;66(11):1736\u20138.","journal-title":"Neurology"},{"key":"4592_CR17","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1097\/CCM.0b013e31829eca06","volume":"41","author":"R Sutter","year":"2013","unstructured":"Sutter R, Kaplan PW, R\u00fcegg S. Independent external validation of the status epilepticus severity score. Crit Care Med. 2013;41:e475\u20139.","journal-title":"Crit Care Med"},{"issue":"5","key":"4592_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"24","key":"4592_CR19","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA. 1993;270(24):2957\u201363.","journal-title":"JAMA"},{"issue":"9","key":"4592_CR20","first-page":"1156","volume":"24","author":"R Sutter","year":"2017","unstructured":"Sutter R, Semmlack S, Spiegel R, Tisljar K, Ruegg S, Marsch S. Distinguishing in-hospital and out-of-hospital status epilepticus: clinical implications from a 10-year cohort study. Eur J Neurol Offi J Eur Fed Neurol Soc. 2017;24(9):1156\u201365.","journal-title":"Eur J Neurol Offi J Eur Fed Neurol Soc"},{"issue":"1","key":"4592_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3\u201323.","journal-title":"Neurocrit Care"},{"issue":"1","key":"4592_CR22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society. Epilepsy Curr. 2016;16(1):48\u201361.","journal-title":"Epilepsy Curr"},{"issue":"39","key":"4592_CR23","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1523\/JNEUROSCI.3440-07.2007","volume":"27","author":"D Kroeger","year":"2007","unstructured":"Kroeger D, Amzica F. Hypersensitivity of the anesthesia-induced comatose brain. J Neurosci Offi J Soc Neurosci. 2007;27(39):10597\u2013607.","journal-title":"J Neurosci Offi J Soc Neurosci"},{"issue":"9","key":"4592_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrneurol.2013.154","volume":"9","author":"R Sutter","year":"2013","unstructured":"Sutter R, Kaplan PW, R\u00fcegg S. Outcome predictors for status epilepticus\u2014what really counts. Nat Rev Neurol. 2013;9(9):525\u201334.","journal-title":"Nat Rev Neurol"},{"key":"4592_CR25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/03610928008827941","volume":"A9","author":"DW Hosmer","year":"1980","unstructured":"Hosmer DW, Lemeshow S. A goodness of-fit test for the multiple logistic regression model. Commu in Stat. 1980;A9:1043\u201369.","journal-title":"Commu in Stat"},{"issue":"2","key":"4592_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","volume":"51","author":"J Novy","year":"2010","unstructured":"Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251\u20136.","journal-title":"Epilepsia"},{"issue":"7","key":"4592_CR27","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/epi.14434","volume":"59","author":"D Fatuzzo","year":"2018","unstructured":"Fatuzzo D, Novy J, Rossetti AO. Use of newer antiepileptic drugs and prognosis in adults with status epilepticus: comparison between 2009 and 2017. Epilepsia. 2018;59(7):e98\u2013102.","journal-title":"Epilepsia"},{"issue":"4","key":"4592_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-017-0424-1","volume":"31","author":"I Beuchat","year":"2017","unstructured":"Beuchat I, Novy J, Rossetti AO. Newer antiepileptic drugs in status epilepticus: prescription trends and outcomes in comparison with traditional agents. CNS Drugs. 2017;31(4):327\u201334.","journal-title":"CNS Drugs"},{"issue":"9","key":"4592_CR29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/epi.13837","volume":"58","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Ansorge S, Hapfelmeier J, Bonthapally V, Erder MH, Rosenow F. Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany. Epilepsia. 2017;58(9):1533\u201341.","journal-title":"Epilepsia"},{"key":"4592_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clineuro.2016.12.017","volume":"154","author":"M Belluzzo","year":"2017","unstructured":"Belluzzo M, Furlanis G, Stragapede L, Monti F. Role of comorbidities and in-hospital complications in short-term status epilepticus outcome. Clin Neurol Neurosurg. 2017;154:13\u20138.","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"4592_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.seizure.2014.04.012","volume":"23","author":"J Zelano","year":"2014","unstructured":"Zelano J, Moller F, Dobesberger J, Trinka E, Kumlien E. Infections in status epilepticus: a retrospective 5-year cohort study. Seizure. 2014;23(8):603\u20136.","journal-title":"Seizure"},{"issue":"3","key":"4592_CR32","volume":"10","author":"CT Ong","year":"2015","unstructured":"Ong CT, Sheu SM, Tsai CF, Wong YS, Chen SC. Age-dependent sex difference of the incidence and mortality of status epilepticus: a twelve year nationwide population-based cohort study in Taiwan. PLoS ONE. 2015;10(3): e0122350.","journal-title":"PLoS ONE"},{"issue":"6","key":"4592_CR33","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1212\/WNL.0000000000012292","volume":"97","author":"P De Stefano","year":"2021","unstructured":"De Stefano P, Baumann SM, Semmlack S, Ruegg S, Marsch S, Seeck M, et al. Safety and efficacy of coma induction following first-line treatment in status epilepticus: a 2-center study. Neurology. 2021;97(6):e564\u201376.","journal-title":"Neurology"},{"issue":"6","key":"4592_CR34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/CCM.0000000000005469","volume":"50","author":"LJ Modra","year":"2022","unstructured":"Modra LJ, Higgins AM, Abeygunawardana VS, Vithanage RN, Bailey MJ, Bellomo R. Sex differences in treatment of adult intensive care patients: a systematic review and meta-analysis. Crit Care Med. 2022;50(6):913\u201323.","journal-title":"Crit Care Med"},{"issue":"12","key":"4592_CR35","doi-asserted-by":"crossref","first-page":"e1242","DOI":"10.1097\/CCM.0000000000004658","volume":"48","author":"M Kaufmann","year":"2020","unstructured":"Kaufmann M, Perren A, Cerutti B, Dysli C, Rothen HU, Swiss Society of Intensive Care M. Severity-adjusted ICU mortality only tells half the truth-the impact of treatment limitation in a nationwide database. Crit Care Med. 2020;48(12):e1242\u201350.","journal-title":"Crit Care Med"},{"issue":"9","key":"4592_CR36","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/aas.13411","volume":"63","author":"L Block","year":"2019","unstructured":"Block L, Petzold M, Syrous AN, Lindqvist B, Odenstedt Herges H, Naredi S. Age, SAPS 3 and female sex are associated with decisions to withdraw or withhold intensive care. Acta Anaesthesiol Scand. 2019;63(9):1210\u20135.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"11","key":"4592_CR37","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00134-022-06836-5","volume":"48","author":"CE Gebhard","year":"2022","unstructured":"Gebhard CE, Hamouda N, Gebert P, Regitz-Zagrosek V, Gebhard C, Investigators C. Sex versus gender-related characteristics: which predicts clinical outcomes of acute COVID-19? Intensive Care Med. 2022;48(11):1652\u20135.","journal-title":"Intensive Care Med"},{"issue":"2","key":"4592_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jacc.2015.10.067","volume":"67","author":"R Pelletier","year":"2016","unstructured":"Pelletier R, Khan NA, Cox J, Daskalopoulou SS, Eisenberg MJ, Bacon SL, et al. Sex versus gender-related characteristics: Which predicts outcome after acute coronary syndrome in the young? J Am Coll Cardiol. 2016;67(2):127\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"4592_CR39","volume":"365","author":"J Thornton","year":"2019","unstructured":"Thornton J. WHO report shows that women outlive men worldwide. BMJ. 2019;365: l1631.","journal-title":"BMJ"},{"issue":"12","key":"4592_CR40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1503\/cmaj.071112","volume":"177","author":"RA Fowler","year":"2007","unstructured":"Fowler RA, Sabur N, Li P, Juurlink DN, Pinto R, Hladunewich MA, et al. Sex-and age-based differences in the delivery and outcomes of critical care. CMAJ. 2007;177(12):1513\u20139.","journal-title":"CMAJ"},{"key":"4592_CR41","doi-asserted-by":"crossref","unstructured":"Hill A, Ramsey C, Dodek P, Kozek J, Fransoo R, Fowler R, et al. Examining mechanisms for gender differences in admission to intensive care units. Health Serv Res. 2019.","DOI":"10.1111\/1475-6773.13215"},{"issue":"4","key":"4592_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/03009734.2012.703255","volume":"117","author":"S Jacobson","year":"2012","unstructured":"Jacobson S, Liedgren E, Johansson G, Ferm M, Winso O. Sequential organ failure assessment (SOFA) scores differ between genders in a sepsis cohort: Cause or effect? Ups J Med Sci. 2012;117(4):415\u201325.","journal-title":"Ups J Med Sci"},{"issue":"9","key":"4592_CR43","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1528-1167.2006.00672.x","volume":"47","author":"HE Scharfman","year":"2006","unstructured":"Scharfman HE, MacLusky NJ. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia. 2006;47(9):1423\u201340.","journal-title":"Epilepsia"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04592-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:19:33Z","timestamp":1700227173000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04592-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04592-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the 1964 Declaration of Helsinki and its subsequent revisions, the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz) granted approval for the study. The requirement for obtaining patient consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SMB declares no competing interests. PDS was supported by the Swiss National Science Foundation (163398, CRS115-180365) and is supported by the 2022 Swiss League Against Epilepsy Research Support Prize. PSCK declares no competing interests. PG declares no competing interests. CEG has received speakers\u2019 fees from Sanofi Genzyme, travel support from Siemens Healthineers, and research support from the Novartis Foundation, Switzerland, and Bayer Pharmaceuticals. OEG declares no competing interests. GMDM has been receiving support from the Swiss National Science Foundation (Nr 32003B_200573, Nr. PBBEP3_139388); Spezialprogramm Nachwuchsf\u00f6rderung Klinische Forschung, University of Basel; Science Funds (Wissenschaftspool) of the University Hospital Basel; Swiss Heart Foundation; ProPatient Foundation Basel; Bangerter-Rhyner-Stiftung; Swisslife Jubil\u00e4umsstiftung for Medical Research; Swiss Neurological Society; Fondazione Dr Ettore Balli; De Quervain research grant; Thermo Fisher GmbH; Novartis grant; travel honoraria by Bayer and BMS\/Pfizer; speaker honoraria by Bayer and Medtronic; consultant honoraria by Bayer and Novartis. He is member of the Steering Committee of PACIFIC Stroke (NCT04304508). Industry payments are made to the research fund of the University Hospital Basel. SH is supported by the Swiss National Foundation (SNF) (Ref 10001C_192850\/1 and 10531C_182422), the Gottfried Julia Bangerter-Rhyner Foundation (8472\/HEG-DSV), and the Swiss Society of General Internal Medicine (SSGIM). SR received unconditional research grants from UCB-pharma. He received honoraria from serving on the scientific advisory boards of Angellini\/Arvelle, Bial, Eisai, GW, and UCB-pharma, and from serving as a consultant for Angellini\/Arvelle, Eisai, Pfizer, Novartis, Sandoz, and UCB-pharma. He does not hold any stocks of any pharmaceutical industries or manufacturers of medical devices. He received funding from UCB-pharma, and Swiss National Science Foundation Grants: Grant Number 320030_169379\/1 and coapplicant for grants numbers 33CM30_125115\/1 and 33CM30_140338\/1; he disclosed that he is the past-president of the Swiss League against Epilepsy (no payments). AK has received honoraria for consulting from Abbvie, EliLilly, Lundbeck, Mitsubishi Tanabe, Novartis, and TEVA that were paid to a teaching and research fund at the University Hospital Geneva. JP declares no competing interests. HQ declares no competing interests. SM declares no competing interests. MS is a shareholder of Epilog NV (Ghent, Belgium). She received speaker's fees from Philips and Desitin. She received grants from the Swiss National Science Foundation (163398, CRS115-180365). RS received research grants from the Swiss National Foundation (Ref 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received personal grants from UCB-pharma and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}